Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Clinical trial NCT03473730 · COMPLETED

Trial details

NCT number: NCT03473730
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Bladder Urothelial Carcinoma Clear Cell Renal Cell Carcinoma Malignant Urinary System Neoplasm Metastatic Kidney Carcinoma Stage IV Renal Cell Cancer AJCC V8

Start date: 2018-05-29
Primary completion: 2025-01-27
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.